Aphria Story

APHA -- USA Stock

USD 18.95 2.24 13.41%

Macroaxis Story

Aphria Current Ratio is projected to decrease significantly based on the last few years of reporting. The past year's Current Ratio was at 4.77. The current year Gross Margin is expected to grow to 0.45, whereas Average Assets are forecasted to decline to about 2.5 B. As some conservative investors are getting more into healthcare space, Aphria Inc could be a your radar. We will cover the possibilities of making Aphria into a steady grower in February. In this post, I will also go over a few different drivers affecting Aphria's products and services, and explain how it may impact Aphria investors.

Published over a month ago

View all stories for Aphria | View All Stories

Aphria (NYSE:APHA) continues to rise

This firm's average rating is Buy from 10 analysts. Our trade advice tool can cross-verify current analyst consensus on Aphria Inc and to analyze the company potential to grow in the current economic cycle.

How important is Aphria's Liquidity

Aphria financial leverage refers to using borrowed capital as a funding source to finance Aphria Inc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Aphria financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Aphria's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.

It is good to see analyst projects for Aphria, but it might be worth checking our own buy vs. sell analysis

What did Aphria file with SEC?

The SEC filings are financial statements or other formal documents of Aphria Inc that are regularly submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make SEC filings and fintech professionals rely on these filings for information about companies they are evaluating for investment purposes. Please note, most SEC filings are available online through the SEC's EDGAR database.

Please check here for more information.

Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Aphria shareholders may or may not be submitted as SEC does not always require it.

23rd of February 2021

Other Events

View

What is the case for Aphria Investors

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aphria has an asset utilization ratio of 5.0 percent. This suggests that the company is making $0.05 for each dollar of assets. An increasing asset utilization means that Aphria Inc is more efficient with each dollar of assets it utilizes for everyday operations.

Aphria implied volatility may change after the rise

The coefficient of variation is down to 521.33 as of today. Aphria Inc exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Aphria Inc individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Aphria future systematic risk.

Our Conclusion on Aphria

Whereas many of the other players under the drug manufacturers?specialty & generic industry are still a bit expensive, Aphria may offer a potential longer-term growth to investors. With a relatively neutral outlook on the current economy, it is better to hold off any trading of Aphria as the current risk-reward utility is not appealing enough. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Aphria.

About Contributor

Achuva Shats is a Member of Macroaxs Editorial Board. Achuva writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Aphria Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC